HALEY SPENCER: Open Payments
NPI 1194281188 · SEARCY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,023 in 61 payments from 10 companies in 2025. Trend: 2023 $1,518 · 2024 $1,508 · 2025 $1,023
Food & beverage: $1,023
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $282 |
| UCB, Inc. | 11 | $207 |
| ABBVIE INC. | 14 | $173 |
| Novartis Pharmaceuticals Corporation | 7 | $124 |
| Mallinckrodt Hospital Products Inc. | 5 | $96 |
| Genentech USA, Inc. | 2 | $35 |
| Janssen Biotech, Inc. | 2 | $32 |
| SOBI, INC | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| Organon LLC | 1 | $21 |
Products named: Bimzelx, ENBREL, COSENTYX, ACTHAR, RINVOQ, SKYRIZI, TAVNEOS, OTEZLA.
Industry payments across AR — which companies pay providers there.
